1-14 of 14
Jamie D. Cavenagh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature

Michael A. Chapman, Jonathan Sive, John Ambrose, Claire Roddie, Nicholas Counsell, Anna Lach, Mahnaz Abbasian, Rakesh Popat, Jamie D. Cavenagh, Heather Oakervee, Matthew J. Streetly, Stephen Schey, Mickey Koh, Fenella Willis, Andres E. Virchis, Josephine Crowe, Michael F. Quinn, Gordon Cook, Charles R. Crawley, Guy Pratt, Mark Cook, Nivette Braganza, Toyin Adedayo, Paul Smith, Laura Clifton-Hadley, Roger G. Owen, Pieter Sonneveld, Jonathan J. Keats, Javier Herrero, Kwee Yong
Journal: Blood
Blood (2018) 132 (20): 2154–2165.
https://doi.org/10.1182/blood-2018-05-849893
Published: 2018
Includes: Supplemental data
Journal Articles

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

Clinical Trials & Observations
Thierry Facon, Meletios A. Dimopoulos, Angela Dispenzieri, John V. Catalano, Andrew Belch, Michele Cavo, Antonello Pinto, Katja Weisel, Heinz Ludwig, Nizar J. Bahlis, Anne Banos, Mourad Tiab, Michel Delforge, Jamie D. Cavenagh, Catarina Geraldes, Je-Jung Lee, Christine Chen, Albert Oriol, Javier De La Rubia, Darrell White, Daniel Binder, Jin Lu, Kenneth C. Anderson, Philippe Moreau, Michel Attal, Aurore Perrot, Bertrand Arnulf, Lugui Qiu, Murielle Roussel, Eileen Boyle, Salomon Manier, Mohamad Mohty, Herve Avet-Loiseau, Xavier Leleu, Annette Ervin-Haynes, Guang Chen, Vanessa Houck, Lotfi Benboubker, Cyrille Hulin
Journal: Blood
Blood (2018) 131 (3): 301–310.
https://doi.org/10.1182/blood-2017-07-795047
Published: 2018
Includes: Supplemental data
Journal Articles

Immune Biomarkers Identify Sustained Quantitative and Functional Immune Reconstitution in the Setting of Adjunctive Lenalidomide Following T-Depleted RIC-Allo SCT for Multiple Myeloma

Gordon Cook, MD PhD, Clive R Carter, PhD, Kristian Brock, MSc, BSc, Grant McQuaker, MD, John A Snowden, Charles Crawley, Hannah Hunter, Jamie D. Cavenagh, Mark Lobb, BSc(Hons), Katherine Cullen, BSc, MSc, Andrea Hodgkinson, Mirjana Sirovica, Mark Cook, PhD MBChB
Journal: Blood
Blood (2016) 128 (22): 4585.
https://doi.org/10.1182/blood.V128.22.4585.4585
Published: 2016
Journal Articles

Vorinostat Does Not Improve Outcome in Patients with Acute Myeloid Leukemia and High Risk Myelodysplasia Treated with Azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial

Charles Craddock, MD PhD, Aimee E Houlton, BSc, MSc, Paul Ferguson, MBChB MRCP PhD, Manoj Raghavan, Sonia Fox, Louise Dudley, BSc, MRes, Lynn Swun Quek, FRCPath, DPhil, MBBS, Jamie D. Cavenagh, Michael Dennis, FRCPath, Mary Frances McMullin, MD, Srinivas P Pillai, Richard Kelly, BSc, MD, Shamyla Siddique, Keith Wheatley, DPhil, Paresh Vyas, BM, DPhil, FRCP, FRCPath
Journal: Blood
Blood (2016) 128 (22): 1065.
https://doi.org/10.1182/blood.V128.22.1065.1065
Published: 2016
Journal Articles

Variable Penetrance Is Linked with Monoallelic Gene Expression in Inherited GATA2 -Mutated MDS/AML

Ahad Al Seraihi, BSc, MSc, Ana Rio-Machin, BSc, MSc, PhD, Kiran Tawana, MD PhD, Csaba Bödör, BSc, PhD, Shamzah Araf, MD, James A Heward, BSc, PhD, Matthew Smith, MBBS, MA, MRCP, MRCPath, MD, Sameena Iqbal, Steven Best, PhD, Nicholas Lea, PhD, Donal McLornan, MB, Bch (Hons), PhD MRCP, FRCPath, Alicia Ellison, BSc, Hemanth Tummala, PhD, Shirleny Romualdo Cardoso, BSc, Jamie D. Cavenagh, Tom Vulliamy, FRCPath, Inderjeet Dokal, MD FRCPCH, FRCPath, FMedSci, Jude Fitzgibbon
Journal: Blood
Blood (2016) 128 (22): 3916.
https://doi.org/10.1182/blood.V128.22.3916.3916
Published: 2016
Journal Articles

Final Analysis of Overall Survival from the First Trial

Thierry Facon, Meletios A Dimopoulos, Angela Dispenzieri, John V. Catalano, Andrew Belch, Michele Cavo, MD, Antonello Pinto, Katja Weisel, Heinz Ludwig, Nizar J. Bahlis, MD, Anne Banos, Mourad Tiab, Michel Delforge, Jamie D. Cavenagh, Catarina Geraldes, Je-Jung Lee, Christine Chen, Albert Oriol, Javier De La Rubia, Darrell White, Daniel Binder, Jin Lu, Kenneth C. Anderson, Philippe Moreau, Michel Attal, Jean-Paul Fermand, Herve Avet-Loiseau, Annette Ervin-Haynes, Guang Chen, Vanessa Houck, Cyrille Hulin, Lofti Benboubker
Journal: Blood
Blood (2016) 128 (22): 241.
https://doi.org/10.1182/blood.V128.22.241.241
Published: 2016
Journal Articles

Panobinostat Plus Azacitidine in Adult Patients with MDS, CMML, or AML: Results of a Phase 2b Study

Guillermo Garcia-Manero, MD, Mikkael A. Sekeres, MD MS, Miklos Egyed, MDPhD Prof., Giuliana Alimena, MD, Carlos Graux, Jamie D. Cavenagh, MD, Huda Salman, Arpad Illes, MD PhD, Pierre Fenaux, MD PhD, Daniel J. DeAngelo, Reinhard Stauder, MD MSc, Karen Yee, MD, Nancy Y Zhu, MDFRCPC, Je-Hwan Lee, MD PhD, David Valcarcel, MD PhD, Alan MacWhannell, Zita Borbenyi, MD PhD, Antje Wegener, Lucien Gazi, Suddhasatta Acharyya, PhD, Florence Binlich, Oliver G. Ottmann, MD
Journal: Blood
Blood (2015) 126 (23): 2861.
https://doi.org/10.1182/blood.V126.23.2861.2861
Published: 2015
Journal Articles

Development of original donor cell leukemia after successful engraftment from a second donor

Jane M. Stevens, Denise Syndercombe-Court, Heather E. Oakervee, Daniel McCloskey, Michael J. Jenner, John G. Gribben, Jamie D. Cavenagh
Journal: Blood
Blood (2007) 110 (13): 4621–4622.
https://doi.org/10.1182/blood-2007-07-104240
Published: 2007
Journal Articles

Reduced Dose PAD Combination Therapy (PS-341/Bortezomib, Adriamycin and Dexamethasone) for Previously Untreated Patients with Multiple Myeloma.

Rakesh Popat, MBBS, Heather E. Oakervee, MRCPath, Nicola Curry, MBBS, Nicola Foot, BSc, Curly Morris, FRCP, Mary Drake, MRCPath, Samir Agrawal, PhD, Patricia Smith, RGN, David Schenkein, MD, Dixie-Lee Esseltine, MD, Jamie D. Cavenagh, MD
Journal: Blood
Blood (2005) 106 (11): 2554.
https://doi.org/10.1182/blood.V106.11.2554.2554
Published: 2005
Journal Articles

A Phase I/II Study of Bortezomib and Low Dose Intravenous Melphalan (BM) for Relapsed Multiple Myeloma.

Rakesh Popat, DipRCPath, Heather E. Oakervee, MRCPath, Nicola Foot, BSc, Samir Agrawal, PhD, Patricia Smith, RGN, Charles Craddock, FRCPath, Catherine Williams, FRCPath, Supratik Basu, FRCPath, Jamie D. Cavenagh, MD
Journal: Blood
Blood (2005) 106 (11): 2555.
https://doi.org/10.1182/blood.V106.11.2555.2555
Published: 2005
Journal Articles

Changes in Mcl-1 and Bim Expression with Bortezomib and Melphalan Therapy for Multiple Myeloma.

Rakesh Popat, DipRCPath, Lyndsey Goff, PhD, Heather E. Oaekervee, MRCPath, Jamie D. Cavenagh, MD, Simon P. Joel, PhD
Journal: Blood
Blood (2005) 106 (11): 2481.
https://doi.org/10.1182/blood.V106.11.2481.2481
Published: 2005
Journal Articles

Flow Cytometric FLT3 Expression in Acute Leukaemias Is of Diagnostic Value but Does Not Correlate with ITD / D835Y Mutation Status.

Colin Ridler, Matthew Smith, Tim Milne, Fatema Ebrahim, Marion Macey, T. A. Lister, Jude Fitzgibbon, Jamie D. Cavenagh, Samir G. Agrawal
Journal: Blood
Blood (2004) 104 (11): 3014.
https://doi.org/10.1182/blood.V104.11.3014.3014
Published: 2004
Journal Articles

Incidence of ZAP70 Positivity in Fresh Samples from Unselected Patients Presenting with a B-Cell Lymphoproliferative Disorder.

James A. Petrie, Tim Milne, Fatema Ebrahim, Jamie D. Cavenagh, Samir G. Agrawal
Journal: Blood
Blood (2004) 104 (11): 4399.
https://doi.org/10.1182/blood.V104.11.4399.4399
Published: 2004
Journal Articles

CD123 Expression in Chronic Lymphocytic Leukaemia - Strong Correlation with ZAP70 and CD38 Expression.

James A. Petrie, Tim Milne, Colin Ridler, Jamie D. Cavenagh, Samir G. Agrawal
Journal: Blood
Blood (2004) 104 (11): 4406.
https://doi.org/10.1182/blood.V104.11.4406.4406
Published: 2004